Related Experiment Videos

Creatine kinase isoenzymes in serum from children--especially focusing on CK-BB

Insights

Serum creatine kinase-BB (CK-BB) levels in children are highest in infancy and decline with age, suggesting a link to growth. CK-BB is not influenced by seizures or fever in pediatric patients.

Area of Science:

  • Biochemistry
  • Pediatric Medicine
  • Clinical Chemistry

Background:

  • Creatine kinase (CK) isoenzymes, including CK-BB, are crucial biomarkers.
  • Understanding age-related variations in CK isoenzymes is important for pediatric diagnostics.

Purpose of the Study:

  • To investigate the age-dependent changes in serum CK-BB activity in children.
  • To determine the influence of factors like seizures, epilepsy, and body temperature on CK-BB levels.
  • To assess the cardiac specificity of CK-MB in pediatric populations.

Main Methods:

  • Serum samples were collected from 161 children aged 7 months to 18 years.
  • Concentrations of CK-BB and CK-MB were measured.
  • Data were analyzed for correlations with age, seizures, epilepsy, and body temperature.

Main Results:

  • Serum CK-BB was measurable in 58% of children, with levels highest in the first year of life and decreasing with age.
  • CK-BB activity showed a strong resemblance to growth charts and was not significantly affected by seizures, epilepsy, or fever.
  • CK-MB was detected in 7% of children, but its presence could not be attributed to cardiac origin, questioning its cardiac specificity in this age group.

Conclusions:

  • Serum CK-BB levels in children are primarily related to physiological growth processes.
  • CK-BB is the sole CK isoenzyme exhibiting significant age-related changes in children.
  • CK-MB is not reliably indicative of cardiac origin in children, necessitating further investigation for cardiac assessment.

Related Concept Videos